These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML). Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM, Bohlander SK, Braess J, Heinecke A, Sauerland MC, Berdel WE, Buechner T, Woermann BJ, Feuring-Buske M, Buske C, Creutzig U, Thiede C, Zwaan MC, van den Heuvel-Eibrink MM, Reinhardt D, Hiddemann W, Spiekermann K. Ann Hematol; 2012 Jan; 91(1):9-18. PubMed ID: 21744003 [Abstract] [Full Text] [Related]
24. [FLT3 gene mutation and its prognostic implication in patients with acute leukemia.]. Sino-US Shanghai Leukemia Cooperative Group. Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):1-5. PubMed ID: 20302766 [Abstract] [Full Text] [Related]
25. Detailed analysis of FLT3 expression levels in acute myeloid leukemia. Kuchenbauer F, Kern W, Schoch C, Kohlmann A, Hiddemann W, Haferlach T, Schnittger S. Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434 [Abstract] [Full Text] [Related]
27. [FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia]. Han YL, Zhang SJ, Qiao C, Dai D, Sun XM, Xu YL, Qian SX, Xu W, Wang JS, Li JY. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1135-9. PubMed ID: 19840437 [Abstract] [Full Text] [Related]
28. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Stubbs MC, Kim YM, Krivtsov AV, Wright RD, Feng Z, Agarwal J, Kung AL, Armstrong SA. Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551 [Abstract] [Full Text] [Related]
35. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T. Clin Cancer Res; 2005 Feb 15; 11(4):1416-24. PubMed ID: 15746041 [Abstract] [Full Text] [Related]
37. Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML). Boissel N, Leroy H, Brethon B, Philippe N, de Botton S, Auvrignon A, Raffoux E, Leblanc T, Thomas X, Hermine O, Quesnel B, Baruchel A, Leverger G, Dombret H, Preudhomme C, Acute Leukemia French Association (ALFA), Leucémies Aiguës Myéloblastiques de l'Enfant (LAME) Cooperative Groups. Leukemia; 2006 Jun 15; 20(6):965-70. PubMed ID: 16598313 [Abstract] [Full Text] [Related]